Search results
Results from the WOW.Com Content Network
Canine parvovirus (also referred to as CPV, CPV2, or parvo) is a contagious virus mainly affecting dogs and wolves. CPV is highly contagious and is spread from dog to dog by direct or indirect contact with their feces. Vaccines can prevent this infection, but mortality can reach 91% in untreated cases.
Polyclonal antibodies from the sera were then purified and cryo-electron microscopy (cryo-EM) was used to capture high-resolution renderings of the structures of the polyclonal Fab-virus complexes ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
A general representation of the method used to produce monoclonal antibodies [1] [2] A monoclonal antibody (mAb, more rarely called moAb) is an antibody produced from a cell lineage made by cloning a unique white blood cell. All subsequent antibodies derived this way trace back to a unique parent cell.
Adoption of our canine parvovirus monoclonal antibody has been somewhat slower than initially expected as customers balance the vital importance of defending puppies against this deadly virus ...
The first way to prevent a parvovirus infection is by not allowing your puppy to be exposed. ... All puppies who nursed from vaccinated mothers will have antibodies in their bloodstream protecting ...
[citation needed] The monoclonal antibody against the CD20 protein has been shown to cause acute hepatitis, [51] neutropenia via parvovirus B19 reactivations, [52] and even persistent parvovirus B19 infection. [53] However, it is important to note that IVIG therapy is not perfect as 34% of treated patients will have a relapse after 4 months. [50]
They may be infected with parvovirus B19, a disease spreading nationwide that causes a “slapped cheek” rash in children. ... Roughly half of adults have detectable antibodies by the age of 20 ...